請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51362
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳漪紋(Yi-Wen Chen) | |
dc.contributor.author | Chih-lin Chien | en |
dc.contributor.author | 錢之琳 | zh_TW |
dc.date.accessioned | 2021-06-15T13:31:43Z | - |
dc.date.available | 2017-02-26 | |
dc.date.copyright | 2016-02-26 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-02-02 | |
dc.identifier.citation | 1. Mewar, D. and A.G. Wilson, Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother, 2006. 60(10): p. 648-55.
2. Wegner, N., et al., Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev, 2010. 233(1): p. 34-54. 3. Kuo, C.F., et al., Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int, 2013. 33(2): p. 355-60. 4. van der Heijde, D., et al., EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis, 2013. 72(4): p. 479-81. 5. Aase Haj Hensvold , G.R., and Anca I. Catrina, From Citrullination to Specifi c Immunity and Disease in Rheumatoid Arthritis, in Protein Deimination in Human Health and Disease, A.P.N.a.S.K. Bhattacharya, Editor. 2014, Springer Science+Business Media: New York. 6. Kallberg, H., et al., Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet, 2007. 80(5): p. 867-75. 7. Bonfil, J.J., et al., A 'case control' study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). Journal of Clinical Periodontology, 1999. 26(2): p. 77-84. 8. Cecil, R.L., Influential Factors in Recovery from Rheumatoid Arthritis. Annals of Internal Medicine, 1934. 8(3): p. 315. 9. Desvarieux, M., et al., Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation, 2005. 111(5): p. 576-82. 10. Hayashi, C., et al., Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol, 2010. 25(5): p. 305-16. 11. Taylor, B.A., et al., Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J Dent Res, 2006. 85(1): p. 74-8. 12. Tonetti, M.S., et al., Treatment of periodontitis and endothelial function. N Engl J Med, 2007. 356(9): p. 911-20. 13. Marchesan, J.T., et al., Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther, 2013. 15(6): p. R186. 14. Schellekens, G.A., et al., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. , 1998. 101(1): p. 273-81. 15. F. B. Mercado1, R.I.M.a. and P.M. Bartold2, inter-relationships between RA and periodontal disease a review. J Clin Periodontol, 2013. 30. 16. de Pablo, P., T. Dietrich, and T.E. McAlindon, Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol, 2008. 35(1): p. 70-6. 17. Mikuls, T.R., et al., Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol, 2014. 66(5): p. 1090-100. 18. Rosenstein, E.D., et al., Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation, 2004. 28(6): p. 311-8. 19. Lundberg, K., et al., Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol, 2010. 6(12): p. 727-30. 20. Lundberg, K., et al., Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum, 2008. 58(10): p. 3009-19. 21. Mikuls, T.R., et al., Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum, 2012. 64(11): p. 3522-30. 22. Nigrovic PA, L.D., Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007. 217: p. 19-37. 23. de Smit, M., et al., Antibodies against Porphyromonas gingivalis in seropositive arthralgia patients do not predict development of rheumatoid arthritis. Ann Rheum Dis., 2014. 73(6): p. 1277-9. 24. Moen, K., et al., Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol, 2006. 24(6): p. 656-63. 25. Demmer, R.T., et al., Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol, 2011. 38(11): p. 998-1006. 26. Dissick, A., et al., Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol, 2010. 81(2): p. 223-30. 27. Vossenaar, E.R., et al., Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis, 2004. 63(4): p. 373-81. 28. Senshu, T., Studies on specificity of peptidylarginine deiminase reactions using an immunochemical probe that recognizes an enzymatically deiminated partial sequence of mouse keratin K1. Journal of Dermatological Science, 1999. 21(2): p. 113-126. 29. Senshu, T., et al., Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun, 1996. 225(3): p. 712-9. 30. Harding, C.R. and I.R. Scott, Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol, 1983. 170(3): p. 651-73. 31. Pearton DJ, D.B., Presland RB, Functional analysis of the profi laggrin N-terminal peptide: identifi cation of domains that regulate nuclear and cytoplasmic distribution. . J Invest Dermatol, 2002. 119(3): p. 661-669. 32. Moscarello, M.A., et al., Myelin in multiple sclerosis is developmentally immature. J Clin Invest. , 1994. 94(1): p. 146-54. 33. Koch, M.W., L.M. Metz, and O. Kovalchuk, Epigenetic changes in patients with multiple sclerosis. Nat Rev Neurol, 2013. 9(1): p. 35-43. 34. Mohanan S, C.B., Horibata S, McElwee JL, Thompson PR, Coonrod SA Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. . Biochem Res Int 2012. 35. Makrygiannakis D, a.K.E., Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L et al ,, Citrullination is an infl ammation-dependent process. Ann Rheum Dis 2006. 65(9): p. 1219-1222. 36. Quirke, A.M., et al., Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis, 2014. 73(1): p. 263-9. 37. Konig, M.F., et al., Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis., 2015. 74(11): p. 2054-61. 38. de Pablo, P., et al., The anti-citrullinated antibody repertoire in periodontitis: a role in the induction of autoimmunity in rheumatoid arthritis? The Lancet, 2013. 381: p. S35. 39. Nielen, M.M., et al., Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum, 2004. 50(2): p. 380-6. 40. Schellekens, G.A., et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000. 43(1): p. 155-63. 41. van der Helm-van Mil, A.H., et al., Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther, 2005. 7(5): p. R949-58. 42. Quinn, M.A., et al., Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford). 2006. 45(4): p. 478-80. 43. Ioan-Facsinay, A., et al., Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis, 2011. 70(1): p. 188-93. 44. Zendman, A.J., G.J.M. van Venrooij Wj Fau - Pruijn, and G.J. Pruijn, Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford). , 2006. 45(1): p. 20-5. 45. Poulsom, H. and P.J. Charles, Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol, 2008. 34(1): p. 4-10. 46. Damjanovska, L., et al., Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis, 2010. 69(4): p. 730-2. 47. Bang, H., et al., Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum, 2007. 56(8): p. 2503-11. 48. Nicaise Roland, P., et al., Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res Ther, 2008. 10(6): p. R142. 49. Nicaise-Roland, P., et al., Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis. , 2013. 72(3): p. 357-62. 50. Mathsson, L., et al., Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum. , 2008. 58(1): p. 36-45. 51. Kobayashi, T., et al., Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. J Periodontol, 2010. 81(5): p. 650-7. 52. Nilsson, M. and S. Kopp, Gingivitis and periodontitis are related to repeated high levels of circulating tumor necrosis factor-alpha in patients with rheumatoid arthritis. J Periodontol, 2008. 79(9): p. 1689-96. 53. Bozkurt, F.Y., et al., Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis. J Periodontol. , 2000. 71(11): p. 1756-60. 54. Havemose-Poulsen, A., et al., Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol, 2005. 76(12): p. 2276-85. 55. Jansson, H., et al., Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontol, 2006. 33(6): p. 408-14. 56. Armitage, G.C., Development of a classification system for periodontal diseases and conditions. Ann Periodontol, 1999. 4(1): p. 1-6. 57. Armitage, G.C., Diagnosis of periodontal diseases. J Periodontol., 2003. 74(8): p. 1237-47. 58. Chiu, B., Multiple infections in carotid atherosclerotic plaques. Am Heart J, 1999. 138(5 Pt 2): p. S534-6. 59. Madianos, P.N., et al., Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol, 2001. 6(1): p. 175-82. 60. Hutter, J.W., et al., Lower numbers of erythrocytes and lower levels of hemoglobin in periodontitis patients compared to control subjects. Journal of Clinical Periodontology, 2001. 28(10): p. 930-936. 61. Loos, B.G., et al., Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol, 2000. 71(10): p. 1528-34. 62. Wohlfeil, M., et al., Increased systemic elastase and C-reactive protein in aggressive periodontitis (CLOI-D-00160R2). Clin Oral Investig, 2012. 16(4): p. 1199-207. 63. Socransky, S.S. and A.D. Haffajee, Periodontal microbial ecology. Periodontol 2000, 2005. 38: p. 135-87. 64. Hajishengallis, G., Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol, 2015. 15(1): p. 30-44. 65. Graves, D.T., et al., Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res, 2001. 80(10): p. 1875-9. 66. Gaspersic, R., et al., Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. Journal of Periodontal Research, 2003. 38(2): p. 198-203. 67. Kurtis, B., et al., Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol, 2005. 76(11): p. 1849-55. 68. Ikezawa, I., et al., Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis. J Clin Periodontol, 2005. 32(10): p. 1047-54. 69. Nibali, L., et al., Interleukin-6 in oral diseases: a review. Oral Diseases, 2012. 18(3): p. 236-243. 70. Irwin, C.R. and T.T. Myrillas, The role of IL-6 in the pathogenesis of periodontal disease. Oral Diseases, 1998. 4(1): p. 43-47. 71. Fujihashi, K., et al., Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol. , 1993. 142(4): p. 1239-50. 72. Geivelis, M., et al., Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol, 1993. 64(10): p. 980-3. 73. Lee, H.J., et al., The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol, 1995. 22(11): p. 885-90. 74. Costa, P.P., et al., Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol, 2010. 81(3): p. 384-91. 75. Shimada, Y., et al., The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol, 2010. 81(8): p. 1118-23. 76. D'Aiuto, F., et al., Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res, 2005. 84(3): p. 269-73. 77. D'Aiuto, F., et al., Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. , 2004. 83(2): p. 156-60. 78. Pischon, N., et al., Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. , 2008. 79(6): p. 979-86. 79. de Pablo, P., et al., The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis, 2014. 73(3): p. 580-6. 80. Pratesi, F., et al., HLA shared epitope and ACPA: just a marker or an active player? Autoimmun Rev., 2013. 12(12): p. 1182-7. 81. Shapira, L., et al., Sequential manifestation of different forms of early-onset periodontitis. A case report. J Periodontol, 1994. 65(6): p. 631-5. 82. Kobayashi, T. and H. Yoshie, Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis. Curr Oral Health Rep, 2015. 2: p. 1-8. 83. Gaffen, S.L. and G. Hajishengallis, A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res, 2008. 87(9): p. 817-28. 84. Takahashi, K., et al., The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol, 2005. 32(4): p. 369-74. 85. Vernal, R., et al., Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol, 2005. 32(4): p. 383-9. 86. Matusevicius, D., et al., Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler., 1999. 5(2): p. 101-4. 87. Kotake, S., et al., IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. , 1999. 103(9): p. 1345-52. 88. Miossec, P. and J.K. Kolls, Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov, 2012. 11(10): p. 763-76. 89. da Silva, J.C., et al., Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics, 2013. 68(6): p. 766-771. 90. Yue, C., et al., The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol Int, 2010. 30(12): p. 1553-7. 91. Adibrad, M., et al., Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res, 2012. 47(4): p. 525-31. 92. Oda, T., H. Yoshie, and K. Yamazaki, Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiology and Immunology, 2003. 18(1): p. 30-36. 93. Ashimoto, A., et al., Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol, 1996. 11(4): p. 266-73. 94. Laugisch, O., et al., Citrullination in the periodontium-a possible link between periodontitis and rheumatoid arthritis. Clin Oral Investig, 2015. 95. Alessandri, C., et al., Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Annals of the Rheumatic Diseases, 2004. 63(10): p. 1218-1221. 96. Avdeeva, A.S., et al., The relationship of antibodies to modified citrullinated vimentin and markers of bone and cartilage destruction in rheumatoid arthritis. Int J Rheumatol, 2014. 2014: p. 464585. 97. Li, Y., et al., Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients. Rheumatol Int, 2012. 32(8): p. 2415-22. 98. Chen, D.Y., et al., Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther, 2011. 13(4): p. R126. 99. Reyes-Castillo, Z., et al., Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol, 2015. 182(2): p. 119-31. 100. Rutger Persson, G., Rheumatoid arthritis and periodontitis - inflammatory and infectious connections. Review of the literature. J Oral Microbiol, 2012. 4. 101. van den Borne, B.E., et al., Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol, 1997. 24(1): p. 55-60. 102. Howell, T.H. and R.C. Williams, Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med., 1993. 4(2): p. 177-96. 103. Heasman, P.A. and R.A. Seymour, An association between long-term non-steroidal anti-inflammatory drug therapy and the severity of periodontal disease. J Clin Periodontol. , 1990. 17(9): p. 654-8. 104. Gorska, R., et al., Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol., 2003. 30(12): p. 1046-52. 105. Cetinkaya, B., et al., Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis. J Periodontol, 2013. 84(1): p. 84-93. 106. Jackman, R.P., et al., Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol., 2011. 18(2): p. 318-26. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51362 | - |
dc.description.abstract | 研究背景:類風溼性關節炎是一種全身周邊大小多處關節慢性發炎的疾病,現階段致病機轉仍不明,其特點為體內會出現抗瓜胺酸蛋白抗體(anti-citrullinated protein/peptide antibodies,ACPA),屬於自體免疫疾病之一。典型的症狀為關節的軟硬骨變形(deformity)與侵蝕性破壞(erosion)等,這些破壞與基質金屬蛋白(Matrix metalloproteinase,MMP)與其抑制劑(Tissue inhibitor of MMP,TIMP)是否平衡,以及關節組織、血液中骨代謝相關的細胞激素如介白素1(Interleukin-1,IL-1)、介白素6(Interleukin-6,IL-6)、腫瘤壞死因子α(Tumor necrosis factor α,TNF-α)、前列腺素E2(Prostaglandin E2)有關,與牙周病的疾病進程和破壞機轉雷同;近年來發現介白素17(Interleukin-17, IL-17)對疾病破壞的情況與病程變化亦有一定影響。最常被提出有關致病機轉的論調為瓜胺酸化蛋白大量產生,破壞免疫耐受性(immune tolerance)的平衡進而引發強烈免疫反應,造成進一步發炎與破壞;血清學檢查如抗環瓜胺酸胜肽抗體(Anti-cyclic citrullinated peptide antibodies,Anti-CCP)的檢驗在類風溼性關節炎的診斷分類中佔有決定性的影響,學者們也發現血清中抗突變型瓜胺酸波形蛋白抗體(Anti-mutated citrullinated vimentin antibodies)的高低與疾病活動度、疾病嚴重度、以及治療的成效存在正相關,可以利用抗突變瓜胺酸波形蛋白抗體來監測治療的效果。瓜胺酸化(Citrullination)是人體一種蛋白質轉譯後的修飾作用,在原核生物當中,牙周致病菌P.g被發現是唯一擁有具有能將人類纖維蛋白原(fibrinogen)與烯醇酶(α-enolase)瓜胺酸化的酵素,人們懷疑P.g.菌這項能力可能是牙周病與類風溼性關節炎兩病之間的重要關鍵。因此希望能藉由本次實驗來證明類風溼性關節炎與牙周病的關連性;甚至能提前預警類風溼性關節炎或牙周病病友,得到另一個疾病的可能性並及早就醫。
材料與方法:四十二位類風溼性關節炎患者與四十七位健康者進行抽血檢查,以酵素免疫學分析(ELISA)檢測血液中自體免疫抗體抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)、抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)的效價、與細胞激素IL-6、ÍL-17、TNF-α濃度;所有受試者由專業牙周病醫師進行全口牙周檢查,並根據美國牙周病學會的診斷分類方法來診斷受試者牙周病嚴重度;同時也進行口水收集,處理後以聚合酶鏈鎖反應(PCR)和瓊脂膠體電泳(Agarose gel electrophoresis)進行口水中細菌的分析,以檢驗牙周病與類風溼性關節炎之間的相關性。 結論:類風溼性關節炎病友的牙周病盛行率與牙周破壞比對照組更為嚴重,且有統計學上顯著差異;所有受試者在牙周囊袋(pocket depth,PD)大於等於4mm百分比與抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)之間,以及牙周臨床附連喪失(clinical attachment level loss, CAL)大於等於4mm與抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)分別呈現統計學上顯著正相關;顯示牙周發炎與牙周組織破壞的情形確實與類風溼性關節炎血清中抗瓜胺酸蛋白抗體群的效價相關。有趣的是,牙周囊袋大於等於4mm百分比以及牙周臨床附連喪失大於等於4mm百分比,卻分別與血液中IL-17濃度呈現統計學上顯著的負相關,推測血液中細胞激素濃度受到類風溼性關節炎病友臨床用藥相當大的影響。羅吉斯迴歸分析結果顯示牙周附連喪失確實為類風溼性關節炎的風險因子,但IL-6較低反而比較容易得到類風溼性關節炎的結果,可能是因為藥物影響所造成的分析謬誤。 | zh_TW |
dc.description.abstract | Background: Rheumatoid arthritis (RA) is a symmetric, inflammatory, peripheral polyarthritis of unknown etiology. It typically leads to deformity through the stretching of tendons and ligaments and destruction of joints through the erosion of cartilage and bone, which were related to the balance between matrix metalloproteinase(MMP) and tissue inhibitor of MMP(TIMP), the cytokine expression such as interleukin-1, interleukin-6, tumor necrosis factor alpha(TNF-α), and prostaglandin 2, which were similar with the destructive pattern and pathogenesis of periodontitis. The most unique character of RA is the appearance of anti-citrullinated protein/peptide antibodies (ACPA). Serum examination of anti-cyclic citrullinated peptide antibodies (Anti-CCP antibodies) could be one of the tools for RA diagnosis and classification; researchers discovered that serum examination of anti-mutated citrullinated vimentin antibodies (Anti-MCV antibodies) is a reliable parameter for disease activity and drug-effect monitoring. Given inflammatory disease caused by microbial infection, periodontitis was proved relevant to rheumatoid arthritis not only the pattern of destruction but molecular basis of immunity arousal. Last but not least, Porphyromonas ginigivalis, one of the periodontal pathogens, possess peptidylarginine deiminase (PAD). The enzyme (PPAD) functions on C-terminal arginine into citrulline as humans’ does. Experts suspect this could be a possible link between periodontitis and RA. Therefore, we would love to explore the inter-relationship between periodontitis and RA, seeking for possible connections and establishing risk factor models.
Material and methods: We include 42 well-controlled RA patients as study group and 47 systemic healthy subjects as control group. All subjects were received comprehensive periodontal examination to survey periodontal condition, saliva collection for oral pathogen detection by means of PCR and agarose gel electrophoresis, and peripheral venous blood withdrawal for detection of anti-CCP、anti-MCV autoimmune antibodies, as well as IL-6、IL-17、TNF-α by ELISA. Results: The prevalence of periodontitis, inflammatory condition and periodontal destruction were more severe in RA group with significant difference.We’ve noticed there’s positive correlation with significant difference between percentage of PD>=4mm and Anti-CCP, so as to percentage of CAL>=4mm and Anti-MCV. There is no doubt that correlation do exists between periodontal inflammation, destruction and serum level of ACPA. On the other hand, some of the results were controversial. We found both percentage of PD>=4mm and CAL>=4mm NEGATIVELY correlated to serum level of IL-17; the stunning results could be owing to drug effect of RA patients. Logistic regression revealed periodontitis could be the risk factor of RA. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T13:31:43Z (GMT). No. of bitstreams: 1 ntu-105-R01422021-1.pdf: 4488917 bytes, checksum: f1a53ff7a3ef45eb56cf39b39e732bbe (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 目錄
致謝 I 中文摘要 II Abstract IV 第一章、緒論 1 第一節、類風溼性關節炎(Rheumatoid arthritis) 1 1-1 臨床表現與診斷分類 1 1-2 類風溼性關節炎可能的致病機轉與風險因子[5] 4 1-3 瓜胺酸化(Citrullination) 6 1-4 抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)與抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies) 9 1-5 細胞激素與類風溼性關節炎 11 1-6 用藥 12 第二節、牙周病 14 2-1 疾病臨床表現與診斷 14 2-2 致病因子與機轉 14 2-3 細胞激素與牙周病 15 第三節、類風溼性關節炎與牙周病的關係 17 第二章、研究目的 20 第三章、實驗材料與方法 21 第一節、病人募集 21 第二節、臨床牙周檢查 21 第三節、細菌收集與檢測 22 3-1 口水收集與處理 22 3-2 聚合酶鏈鎖反應(Polymerase chain reaction,PCR) 22 3-3 瓊脂膠體電泳(Agarose gel electrophoresis) 23 第四節、血清中自體免疫抗體與細胞激素檢測 24 4-1 血液樣本處理 24 4-2 酵素免疫學分析法(Enzyme-linked immunosorbent assay,ELISA) 24 第五節、統計分析 26 實驗流程圖 27 第四章、結果 28 一、類風溼性關節炎病人疾病情況與藥物使用情形 28 二、類風溼性關節炎病友與健康對照組的牙周健康情況分析 29 三、類風溼性關節炎病友與健康者之間的抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)、抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)分布狀態分析 31 四、類風溼性關節炎病友與健康者之間的腫瘤壞死因子α (TNF-α)、介白素6 (Interleukin 6, IL-6)、介白素17 (Interleukin 17, IL-17)濃度狀態分析 31 五、牙周病與抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)、抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)之間的關係(表5, 6, 7) 32 六、牙周病與介白素6 (Interleukin-6)、介白素17 (Interleukin-17)、腫瘤壞死因子α (TNF-α)的關係(表 5, 6, 7) 33 七、介白素與抗突變型瓜胺酸波形蛋白抗體之間的關係 33 八、牙周病與年齡之間的關係(圖十A、B) 33 九、類風溼性關節炎與風險因子之間的相關性(表 8) 34 第五章、討論 35 第六章、結論 43 參考文獻 62 圖目錄 圖 1類風濕性關節炎病友與健康對照組之間牙周破壞的比較 42 圖 2類風溼性關節炎病友與健康對照組之間抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)、抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)的比較 43 圖 3類風溼性關節炎病人與健康對照組之間腫瘤壞死因子α (TNF-α)的比較 45 圖 4類風溼性關節炎病人與健康對照組之間介白素6(Interleukin 6, IL-6)的比較 46 圖 5類風溼性關節炎病人與健康對照組介白素17(Interleukin 17, IL-17)的比較 47 圖 6牙周病與抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)、抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)在所有研究樣本集合中的相關性 49 圖 7抗環瓜胺酸胜肽抗體(Anti-CCP antibodies)與抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)在所有研究樣本集合中的相關性 51 圖 8牙周病與介白素6 (Interleukin-6)、介白素17 (Interleukin-17)在所有研究樣本集合中的相關性 53 圖 9介白素17(Interleukin 17)與抗突變型瓜胺酸波形蛋白抗體(Anti-MCV antibodies)之間在所有研究樣本中的相關性 55 圖 10牙周病與年齡之間的相關性 56 表目錄 表 1 AAP classification of chronic periodontitis (Armitage 1999) 59 表 2 Demographic data of study objects 59 表 3 The prevalence and severity of periodontitis 59 表 4 The microbial analysis in saliva of study subjects 60 表 5 Correlations between clinical and serum factors in All subjects 60 表 6 Correlations between clinical and serum factors in RA patients 60 表 7 Correlations between clinical and serum factors in Healthy controls 60 表 8 Logistic regression model 61 | |
dc.language.iso | zh-TW | |
dc.title | 自體免疫抗體在牙周病與類風溼性關節炎之間所扮演的角色 | zh_TW |
dc.title | The role of autoimmune antibodies between periodontitis and rheumatoid arthritis | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-1 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 郭彥彬(Mark Yen-Ping Kuo) | |
dc.contributor.oralexamcommittee | 許秉寧(Ping-Ning Hsu) | |
dc.subject.keyword | 抗環瓜胺酸胜?抗體,抗突變型瓜胺酸波形蛋白抗體,牙周囊袋,牙周臨床附連喪失,介白素17,類風溼性關節炎, | zh_TW |
dc.subject.keyword | Anti-CCP antibodies,Anti-MCV antibodies,pocket depth,clinical attachment loss,interleukin 17,rheumatoid arthritis, | en |
dc.relation.page | 69 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-02-03 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
顯示於系所單位: | 臨床牙醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 4.38 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。